Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST-Reference-Cited by-同舟云学术

Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST

Published:2005-06 Issue:16_suppl Volume:23 Page:4000-4000
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Demetri G. D.¹,van Oosterom A. T.¹,Blackstein M.¹,Garrett C.¹,Shah M.¹,Heinrich M.¹,McArthur G.¹,Judson I.¹,Baum C. M.¹,Casali P. G.¹

Affiliation:

1. Dana-Farber Cancer Inst, Boston, MA; UZ Gasthuisberg, Leuven, Belgium; Mount Sinai Hosp and the Univ of Toronto, Toronto, ON, Canada; H. Lee Moffitt Cancer Ctr, Tampa, FL; The Ohio State Univ, Columbus, OH; OHSU Cancer Ctr and Portland VA Medcl Ctr, Portland, OR; Peter MacCallum Cancer Ctr, East Melbourne, Australia; Royal Marsden Hosp, Sutton, United Kingdom; Pfizer, Inc., La Jolla, CA; Inst Nazionale Tumori, Milan, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.4000

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity;Side Effects of Cancer Therapy;2023-12-11

2. Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study;Frontiers in Pharmacology;2023-11-10

3. Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis;Journal of Medicinal Chemistry;2021-10-08

4. Cardiotoxicity;Side Effects of Medical Cancer Therapy;2018

5. In-silico identification of inhibitors against mutated BCR-ABL protein of chronic myeloid leukemia: a virtual screening and molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2016-01-08